News & Updates

Findings from the EquiOx trial presented at ACC.25 underpin the influence of skin pigmentation in pulse oximetry.

For physicians requiring coagulation factor replacement to control bleeding after CPB during surgery, 4F-PCC provides superior haemostatic efficacy over frozen plasma, along with some safety advantages, as shown in the FARES-II trial presented at ACC.25

Consuming pecans as an alternative to usual snacks may improve lipids/lipoproteins and diet quality in adults at increased risk of cardiometabolic diseases, suggests a study. However, pecan intake does not appear to have any effect on vascular health.

Significant treatment gaps persist in lipid management among individuals at very high cardiovascular risk, with up to 80 percent of patients not achieving their low-density lipoprotein cholesterol (LDL-C) goals, reports a Singapore study.

Papillary thyroid cancer (PTC) in individuals with arterial hypertension is independently associated with a diagnosis of primary aldosteronism (PA), reports a study.

Pacemaker implantation after transcatheter aortic valve implantation (TAVI) was associated with a significantly worse prognosis in terms of all-cause and cardiovascular (CV) mortality, according to the SwissTAVI trial presented at EHRA 2025.

Thromboprophylaxis with low molecular weight heparin (LMWH) appears to protect against the onset of superimposed pre-eclampsia, independently from aspirin use, reports a recent study.

In the final results of the CEASE-AF* trial, a hybrid ablation strategy outshines a catheter ablation approach for the treatment of individuals with non-paroxysmal atrial fibrillation (AF).

The first-in-class monoclonal antibody bentracimab effectively and safely reverses the antiplatelet effects of ticagrelor in patients with an indication for urgent or emergent surgery or with major bleeding in the single-arm phase III REVERSE-IT trial.

Atrial fibrillation (AF) carries a heightened risk of dementia, especially for those under 70 years of age, according to a European population-based study said to be the largest to date.